This comprehensive strategy provides clarity, confidence, and care in a GLP-1-influenced food environment
While our study was observational and does not definitively confirm an association between GLP-1 medications and reduced breast cancer incidence, it does add to the growing body of evidence suggesting that its worth investigating these weight-loss drugs as potential cancer prevention tools, said Elizabeth McDonald, MD, PhD, professor of radiology at Penn Medicine and lead investigator of the study
See availability Join our waiting list to secure the early bird price of 380 USD per pen
One possible way to stop the weight from coming back is to transition to other medications or scale back the dose rather than stop treatment altogether
The good news is that most individuals recover once their bodies stabilize
SURMOUNT-5: Greater loss of weight, waist circumference with tirzepatide than semaglutide